Zelin Zhang

Jan 13, 2025 | mdpi.com | Lin Li |Zhixin Jin |Junji Li |Zelin Zhang

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Dec 2, 2023 | mdpi.com | Zheng Ma |Zelin Zhang |Zhaohui Zhang |Zhiqiang Song

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Jul 6, 2023 | dl.begellhouse.com | Zelin Zhang

linc00511 knockdown inhibits Lung cancer progression by regulating miR-16-5p/MMP11Volume 33,Issue 7, 2023,DOI: 10.1615/CritRevEukaryotGeneExpr.2023047789Get accessZelin ZhangXiangyang No.1 People's HospitalABSTRACTBackground: Lung cancer (LC) is a malignant tumor that extremely impairs people. According to numerous studies, long non-coding RNA (lncRNA) was inextricably involved in the advancement of LC.